Fundraising Fox
Paralos Bio
1 known investors
Find your way into Paralos Bio
Sign up to see every warm intro you have to Paralos Bio
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Paralos Bio team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Paralos is developing a modular M13 phage drug delivery platform that creates phage-drug conjugates to concentrate therapeutic payloads at specific targets. The platform pairs programmable target binding with payload presentation to localize drug exposure and engineer delivery around the therapeutic window.
Investors · 1
Frequently asked questions
- What does Paralos Bio do?
- Paralos is developing a modular M13 phage drug delivery platform that creates phage-drug conjugates to concentrate therapeutic payloads at specific targets. The platform pairs programmable target binding with payload presentation to localize drug exposure and engineer delivery around the therapeutic window.
- Who are Paralos Bio's investors?
- Paralos Bio's investors include Carbon Silicon.